(+)-Borneol Protects Dopaminergic Neuronal Loss in Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson’s Disease Mice: A Study of Dopamine Level using In Vivo Brain Microdialysis
ACS Chemical Neuroscience · 05.06.2024 · 15 (11) · 2308-2321
DOI: 10.1021/acschemneuro.4c00139 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, online erschienen am 15.05.2024. Verfasst von Lina Ding und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Anhui Medical University, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei 230032, China. Hauptthemen laut MEDLINE: Dopamine, Dopaminergic Neurons, Neuroprotective Agents, Microdialysis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Jiangxi University of Traditional Chinese Medicine, Anhui Province Academic and Technical Leaders and Reserve Candidates.
Abstract (Originalsprache)
Considerable research efforts have been directed toward the symptom relief of Parkinson's disease (PD) by attenuating dopamine (DA) depletion. One common feature of these existing therapies is their unavailability of preventing the neurodegenerative process of dopaminergic neurons. (+)-Borneol, a natural highly lipid-soluble bicyclic monoterpene, has been reported to regulate the levels of monoamine neurotransmitters in the central nervous system and exhibit neuroprotective effects. However, the effect of (+)-borneol on the dopaminergic neuronal loss of methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice is not defined. Herein, we first report that 30 mg/kg (+)-borneol significantly attenuated the motor deficits of PD mice, which benefits from markedly increasing the level of DA and decreasing the metabolic rate of DA in the striatum of conscious and freely moving mouse detected by ultraperformance liquid chromatography tandem mass spectrometry online combined with in vivo brain microdialysis sampling. It is worth noting that the enhanced level of DA by (+)-borneol was enabled by the reduction in loss of tyrosine hydroxylase-immunoreactive dopaminergic neurons in the substantia nigra and striatum and promotion of reserpine- or nomifensine-induced DA release in PD mice. Interestingly, (+)-borneol evidently inhibited the decreased expression levels of DA transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) on the MPTP mouse model of PD. Moreover, (+)-borneol suppressed the neuroinflammation by inhibiting the production of IL-1β, IL-6, and TNF-α and attenuated oxidative stress by decreasing the level of MDA and increasing the activities of SOD and GSH-px in PD mice. These findings demonstrate that (+)-borneol protects DA neurons by inhibiting neuroinflammation and oxidative stress. Further research work for the neuroprotection mechanism of (+)-borneol will focus on reactive oxygen species-mediated apoptosis. Therefore, (+)-borneol is a potential therapeutic candidate for retarding the neurodegenerative process of PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Anhui Medical University, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei 230032, China.
- Stomatologic Hospital and College, Anhui Medical University, Key Laboratory of Oral Diseases Research of Anhui Province, Hefei 230032, China.
ORCID-Profile: Qunlin Zhang
Förderung
- Jiangxi University of Traditional Chinese Medicine
- Anhui Province Academic and Technical Leaders and Reserve Candidates
Zitieren
APA
Ding, L., Wang, L., Yang, J., Jiang, C., Sun, X., Huang, H., Zhan, X., Liu, F., & Zhang, Q. (2024). (+)-Borneol Protects Dopaminergic Neuronal Loss in Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson’s Disease Mice: A Study of Dopamine Level using In Vivo Brain Microdialysis. ACS Chemical Neuroscience, 15(11), 2308-2321. https://doi.org/10.1021/acschemneuro.4c00139
Vancouver
Ding L, Wang L, Yang J, Jiang C, Sun X, Huang H, et al. (+)-Borneol Protects Dopaminergic Neuronal Loss in Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson’s Disease Mice: A Study of Dopamine Level using In Vivo Brain Microdialysis. ACS Chemical Neuroscience. 2024;15(11):2308-2321. doi:10.1021/acschemneuro.4c00139
BibTeX
@article{Ding2024,
author = {Ding, Lina and Wang, Long and Yang, Jiaxin and Jiang, Cuicui and Sun, Xifeng and Huang, Huite and Zhan, Xiuyuan and Liu, Feilong and Zhang, Qunlin},
title = {(+)-Borneol Protects Dopaminergic Neuronal Loss in Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson’s Disease Mice: A Study of Dopamine Level using In Vivo Brain Microdialysis},
journal = {ACS Chemical Neuroscience},
year = {2024},
volume = {15},
number = {11},
pages = {2308--2321},
doi = {10.1021/acschemneuro.4c00139}
}
EUVIMED